ArticleCancer2017

Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.

Franck E Nicolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.